Cargando…

Association of Taxane Type With Patient-Reported Chemotherapy-Induced Peripheral Neuropathy Among Patients With Breast Cancer

IMPORTANCE: Understanding the detailed symptom spectrum of chemotherapy-induced peripheral neuropathy (CIPN) could facilitate shared decision-making and promote early intervention. OBJECTIVE: To compare the symptom spectrum of patient-reported CIPN associated with nab-paclitaxel, paclitaxel, and doc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mo, Hongnan, Yan, Xiaoyan, Zhao, Fang, Teng, Yuee, Sun, Xiaoying, Lv, Zheng, Cao, Mengru, Zhao, Jiuda, Song, Guohong, Pan, Bo, Li, Huihui, Zhai, Jingtong, Xu, Binghe, Ma, Fei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Medical Association 2022
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9631104/ https://www.ncbi.nlm.nih.gov/pubmed/36322088 http://dx.doi.org/10.1001/jamanetworkopen.2022.39788

Ejemplares similares

Serum sodium ions and chloride ions associated with taxane-induced peripheral neuropathy in Chinese patients with early-stage breast cancer: A nation-wide multicenter study
por: Zhai, Jingtong, et al.
Publicado: (2022)

Risk factors for chemotherapy‐induced peripheral neuropathy in patients receiving taxane‐ and platinum‐based chemotherapy
por: Molassiotis, Alex, et al.
Publicado: (2019)

The impact of SBF2 on taxane-induced peripheral neuropathy
por: Cunningham, Geneva M., et al.
Publicado: (2022)

Reliability and Validity of the Turkish Version of Chemotherapy-induced Peripheral Neuropathy Assessment Tool for Breast Cancer Patients Receiving Taxane Chemotherapy
por: Simsek, Neriman Yükseltürk, et al.
Publicado: (2018)

Diagnostic tools should be used for the diagnosis of chemotherapy induced peripheral neuropathy in breast cancer patients receiving taxanes
por: van Haren, Frank, et al.
Publicado: (2021)

Investigating the Effect of Zinc on the Prevention of Acute Peripheral Neuropathy in Cancer Patients Treated with Taxanes
por: Haji Gholami, Ali, et al.
Publicado: (2022)

Cold Application and Exercise on Development of Peripheral Neuropathy during Taxane Chemotherapy in Breast Cancer Patients: A Randomized Controlled Trial
por: Şimşek, Neriman Yükseltürk, et al.
Publicado: (2021)

Cryotherapy for Prevention of Taxane-Induced Peripheral Neuropathy: A Meta-Analysis
por: Jia, Junting, et al.
Publicado: (2021)

Incidence density and factors associated with peripheral neuropathy among women with breast cancer during taxane-based chemotherapy
por: Rattanakrong, Nida, et al.
Publicado: (2022)

Acupuncture for the Treatment of Taxane-Induced Peripheral Neuropathy in Breast Cancer Patients: A Pilot Trial
por: Jeong, Young Ju, et al.
Publicado: (2018)

A Prospective Study of Taxane-Induced Neuropathy with Breast Cancer: Proper Assessment Tool for Taxane-Induced Neuropathy
por: Sohn, Eun Hee, et al.
Publicado: (2021)

Chemotherapy-Induced Peripheral Neuropathy (CIPN) in Patients Receiving 4–6 Cycles of Platinum-Based and Taxane-Based Chemotherapy: A Prospective, Single-Center Study from Kosovo
por: Myftiu, Blerim, et al.
Publicado: (2022)

Polymorphisms in AURKA and AURKB are associated with the survival of triple-negative breast cancer patients treated with taxane-based adjuvant chemotherapy
por: Liao, Yuqian, et al.
Publicado: (2018)

Taxane-induced sensory peripheral neuropathy is associated with an SCN9A single nucleotide polymorphism in Japanese patients
por: Tanabe, Yuko, et al.
Publicado: (2020)

A preliminary, prospective study of peripheral neuropathy and cognitive function in patients with breast cancer during taxane therapy
por: Ibrahim, Eiman Y., et al.
Publicado: (2022)

Symptoms of anxiety but not depression before start of taxane-based chemotherapy are associated with peripheral neuropathy: a multicenter study in women with breast cancer
por: Verhoeff-Jahja, Rita, et al.
Publicado: (2022)

HbA1c variability and diabetic peripheral neuropathy in type 2 diabetic patients
por: Su, Jian-bin, et al.
Publicado: (2018)

Identifying Predictors of Taxane-Induced Peripheral Neuropathy Using Mass Spectrometry-Based Proteomics Technology
por: Chen, Emily I., et al.
Publicado: (2015)

Taxane-Induced Peripheral Neurotoxicity
por: Velasco, Roser, et al.
Publicado: (2015)

Effect of Exercise on Chemotherapy-Induced Peripheral Neuropathy Among Patients Treated for Ovarian Cancer: A Secondary Analysis of a Randomized Clinical Trial
por: Cao, Anlan, et al.
Publicado: (2023)

Melatonin, a Promising Role in Taxane-Related Neuropathy
por: Nahleh, Z., et al.
Publicado: (2010)

Charcot-Marie-Tooth gene, SBF2, associated with taxane-induced peripheral neuropathy in African Americans
por: Schneider, Bryan P., et al.
Publicado: (2016)

Safety and tolerability of cryocompression as a method of enhanced limb hypothermia to reduce taxane-induced peripheral neuropathy
por: Bandla, Aishwarya, et al.
Publicado: (2019)

A Multimodal Approach to Discover Biomarkers for Taxane-Induced Peripheral Neuropathy (TIPN): A Study Protocol
por: Sharma, Anukriti, et al.
Publicado: (2022)

Chemotherapy-induced peripheral neuropathy
por: Zhang, Xia, et al.
Publicado: (2017)

A biomarker of aging, p16, predicts peripheral neuropathy in women receiving adjuvant taxanes for breast cancer
por: Mitin, Natalia, et al.
Publicado: (2022)

Psychological distress and quality of life in breast cancer survivors with taxane-induced peripheral neuropathy: A scoping review
por: Schwab, Lauren, et al.
Publicado: (2023)

Overview of neuropathy associated with taxanes for the treatment of metastatic breast cancer
por: Rivera, Edgardo, et al.
Publicado: (2015)

Neoadjuvant chemotherapy outcome with taxane-based versus non-taxane protocols in gastric cancer
por: Kianersi, Shirin, et al.
Publicado: (2023)

Chemotherapy-induced peripheral neuropathy in children and adolescent cancer patients
por: Tay, Nicolette, et al.
Publicado: (2022)

Pathophysiology of Chemotherapy-Induced Peripheral Neuropathy
por: Starobova, Hana, et al.
Publicado: (2017)

Mechanisms of Chemotherapy-Induced Peripheral Neuropathy
por: Zajączkowska, Renata, et al.
Publicado: (2019)

Acupuncture combined with methylcobalamin for the treatment of chemotherapy-induced peripheral neuropathy in patients with multiple myeloma
por: Han, Xiaoyan, et al.
Publicado: (2017)

Association of Cyclin-Dependent Kinases 4 and 6 Inhibitors With Survival in Patients With Hormone Receptor–Positive Metastatic Breast Cancer: A Systematic Review and Meta-analysis
por: Li, Jinming, et al.
Publicado: (2020)

Immune changes in patients with advanced breast cancer undergoing chemotherapy with taxanes
por: Tsavaris, N, et al.
Publicado: (2002)

PGC1α: an emerging therapeutic target for chemotherapy-induced peripheral neuropathy
por: Zhai, Mingzhu, et al.
Publicado: (2023)

Drug treatment for chemotherapy-induced peripheral neuropathy in patients with pancreatic cancer
por: Sugimoto, Mitsuru, et al.
Publicado: (2022)

IMPACT OF CHEMOTHERAPY-INDUCED PERIPHERAL NEUROPATHY ON THE QUALITY OF LIFE IN CANCER PATIENTS
por: Novak, Marica, et al.
Publicado: (2022)

ABCB1 polymorphism predicts the toxicity and clinical outcome of lung cancer patients with taxane‐based chemotherapy
por: Zhong, Jia, et al.
Publicado: (2019)

Acupuncture for the Management of Chemotherapy-Induced Peripheral Neuropathy
por: Visovsky, Constance
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_9an8flc8316q3htshnihh98bad